IN2014DN09383A - - Google Patents

Info

Publication number
IN2014DN09383A
IN2014DN09383A IN9383DEN2014A IN2014DN09383A IN 2014DN09383 A IN2014DN09383 A IN 2014DN09383A IN 9383DEN2014 A IN9383DEN2014 A IN 9383DEN2014A IN 2014DN09383 A IN2014DN09383 A IN 2014DN09383A
Authority
IN
India
Prior art keywords
grape seed
seed extract
anthocyanidins
inflammation
oxidative stress
Prior art date
Application number
Other languages
English (en)
Inventor
Chulani Kappagoda
Britt Burton-Freeman
Indika Edirisingue
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of IN2014DN09383A publication Critical patent/IN2014DN09383A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN9383DEN2014 2012-04-10 2013-04-10 IN2014DN09383A (enExample)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261622339P 2012-04-10 2012-04-10
US13/841,673 US20140023737A1 (en) 2012-04-10 2013-03-15 Modulation of Oxidative Stress, Inflammation, and Impaired Insulin Sensitivity with Grape seed Extract
PCT/US2013/035944 WO2013155166A1 (en) 2012-04-10 2013-04-10 Modulation of oxidative stress, inflammation, and impaired insulin sensitivity with grape seed extract

Publications (1)

Publication Number Publication Date
IN2014DN09383A true IN2014DN09383A (enExample) 2015-07-17

Family

ID=49328123

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9383DEN2014 IN2014DN09383A (enExample) 2012-04-10 2013-04-10

Country Status (5)

Country Link
US (3) US20140023737A1 (enExample)
EP (1) EP2836225A4 (enExample)
CN (1) CN104379157A (enExample)
IN (1) IN2014DN09383A (enExample)
WO (1) WO2013155166A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3270707B1 (en) 2015-03-16 2020-10-28 Nature's Sunshine Products Inc. Phytocomplexes exhibiting multiple, synergistic antioxidant activities
JP7296189B2 (ja) 2016-07-22 2023-06-22 株式会社エーゼット ブドウ種子抽出物を含む更年期障害改善剤
JP7279943B2 (ja) * 2020-07-03 2023-05-23 株式会社エーゼット ブドウ種子抽出物を含む更年期障害改善剤
FR3114497B1 (fr) * 2020-09-29 2023-06-02 Activinside Composition comprenant des monomères de flavanol et de l’ε-viniférine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544581B1 (en) * 1999-06-22 2003-04-08 Canandaigua Wine Company, Inc. Process for extraction, purification and enrichment of polyphenolic substances from whole grapes, grape seeds and grape pomace
AU2006294580B2 (en) * 2005-09-28 2012-07-26 E. & J. Gallo Winery Grape extract, dietary supplement thereof, and processes therefor
JP5230431B2 (ja) * 2005-09-28 2013-07-10 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 前高血圧の個体及び／又はメタボリックシンドロームの個体において血圧を降下させるための方法

Also Published As

Publication number Publication date
CN104379157A (zh) 2015-02-25
US20150258159A1 (en) 2015-09-17
WO2013155166A1 (en) 2013-10-17
EP2836225A1 (en) 2015-02-18
US20150258160A1 (en) 2015-09-17
EP2836225A4 (en) 2015-11-04
US20140023737A1 (en) 2014-01-23

Similar Documents

Publication Publication Date Title
EA201170669A1 (ru) Лечение пирфенидоном пациентов с атипичной функцией печени
PH12015500407A1 (en) Methods of treating hypertriglyceridemia
IN2014KN00996A (enExample)
MX2012007806A (es) Composiciones farmaceuticas para administracion oral de peptidos de insulina.
WO2012023623A3 (ja) ハンター症候群の治療剤
BRPI1007732A2 (pt) aparelho para administração de medicamentos para a administração de um aerossol incluindo um medicamento para um paciente, kit para a administração de um aerossol incluindo um medicamento para um paciente e método de administração de um aerossol incluindo um medicamento para um paciente
NZ606964A (en) A combination pharmaceutical composition and methods of treating diabetes and metabolic disorders
WO2013028818A8 (en) Pyrimido- pyridazinone compounds and use thereof
UA105191C2 (ru) Лечение пирфенидоном пациентов с атипической функцией печени
WO2013155528A3 (en) Methods for reducing brain inflammation, increasing insulin sensitivity, and reducing ceramide levels
IN2014DN09383A (enExample)
MX2014014814A (es) Composicion farmaceutica para el tratamiento de inflamacion y dolor.
HK1202420A1 (en) Methods for treating psoriasis and vascular inflammation
MX368640B (es) Composición farmacéutica para tratar inflamación y dolor.
WO2012125871A3 (en) Aconitine compounds, compositions, uses, and preparation thereof
MX2014003093A (es) Combinacion de pterostilbeno y estatina para el tratamiento de enfermedad metabolica, enfermedad cardiovascular e inflamacion.
MY159675A (en) Clerodane derivatives for modulation of leukotriene receptor activity and related diseases
EA201201308A1 (ru) Противотуберкулезное лекарственное средство на основе 4-тиоуреидоиминометилпиридиния перхлората, способ его получения и способ лечения
RU2011108787A (ru) Способ лечения больных красным плоским лишаем слизистой полости рта
UA64823U (ru) Способ медицинской реабилитации больных синдромом хронической усталости
UA64820U (ru) Способ лечения больных с синдромом повышенной утомляемости на фоне хронической тонзиллярной инфекции
UA64821U (ru) Способ медицинской реабилитации больных хроническим некалькулезным холециститом, соединенным с ожирением
UA56353U (ru) Способ возобновления проходности слезоносового канала у детей с введением лекарственного средства
UA64829U (ru) Способ медицинской реабилитации больных послеродовыми психозами
UA64822U (ru) Способ медицинской реабилитации больных неалкогольным стеатогепатитом